» Articles » PMID: 32341104

Cardiovascular Comorbidity and Its Impact on Patients with COVID-19

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2020 Apr 29
PMID 32341104
Citations 51
Authors
Affiliations
Soon will be listed here.
Citing Articles

The clinical features and outcomes of diabetes patients infected with COVID-19: a systematic review and meta-analysis comprising 192,693 patients.

Liu K, Liu S, Xu T, Qiao H Front Med (Lausanne). 2025; 12:1523139.

PMID: 39944495 PMC: 11813781. DOI: 10.3389/fmed.2025.1523139.


Sustained Vascular Inflammatory Effects of SARS-CoV-2 Spike Protein on Human Endothelial Cells.

Gultom M, Lin L, Brandt C, Milusev A, Despont A, Shaw J Inflammation. 2024; .

PMID: 39739157 DOI: 10.1007/s10753-024-02208-x.


Impact of SARS-CoV-2 infection on patients with myasthenia gravis: a retrospective study in a Chinese population.

Liu P, Li M, Li L, Jia W, Dong H, Qi G Front Neurol. 2024; 15:1482932.

PMID: 39722700 PMC: 11668631. DOI: 10.3389/fneur.2024.1482932.


Real-world analysis of safety, tolerability, and adherence to nirmatrelvir-ritonavir (paxlovid) in primary care COVID-19 outpatients.

Zaharuddin Z, Md Hussin N, Karuppannan M Sci Rep. 2024; 14(1):24750.

PMID: 39433826 PMC: 11494129. DOI: 10.1038/s41598-024-75192-9.


Using a general practice research database to assess the spatio-temporal COVID-19 risk.

Petrof O, Neyens T, Vaes B, Janssens A, Faes C BMC Prim Care. 2024; 25(1):175.

PMID: 38773431 PMC: 11106891. DOI: 10.1186/s12875-024-02423-3.


References
1.
Booth C, Matukas L, Tomlinson G, Rachlis A, Rose D, Dwosh H . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003; 289(21):2801-9. DOI: 10.1001/jama.289.21.JOC30885. View

2.
Alqahtani F, Aleanizy F, Ali El Hadi Mohamed R, Alanazi M, Mohamed N, Alrasheed M . Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study. Epidemiol Infect. 2018; 147:e35. PMC: 6518603. DOI: 10.1017/S0950268818002923. View

3.
Badawi A, Ryoo S . Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis. Int J Infect Dis. 2016; 49:129-33. PMC: 7110556. DOI: 10.1016/j.ijid.2016.06.015. View

4.
Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y . Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55(5). PMC: 7098485. DOI: 10.1183/13993003.00547-2020. View

5.
Alanazi K, Abedi G, Midgley C, Alkhamis A, Alsaqer T, Almoaddi A . Diabetes Mellitus, Hypertension, and Death among 32 Patients with MERS-CoV Infection, Saudi Arabia. Emerg Infect Dis. 2019; 26(1):166-168. PMC: 6924889. DOI: 10.3201/eid2601.190952. View